Terms: = Liver cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
421 results:
1. A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients.
Xiong SP; Wang CH; Zhang MF; Yang X; Yun JP; Liu LL
J Transl Med; 2024 May; 22(1):472. PubMed ID: 38762511
[TBL] [Abstract] [Full Text] [Related]
2. Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I; Pastorino L; Andreotti V; Comandini D; Fornarini G; Grassi M; Puccini A; Tanda ET; Pastorino A; Martelli V; Mastracci L; Grillo F; Cabiddu F; Guadagno A; Coco S; Allavena E; Barbero F; Bruno W; Dalmasso B; Bellomo SE; Marchiò C; Spagnolo F; Sciallero S; Berrino E; Ghiorzo P
J Transl Med; 2024 May; 22(1):462. PubMed ID: 38750555
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
4. A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.
Xie Z; Hao Q; Zhu R; Ma R
Can J Gastroenterol Hepatol; 2024; 2024():2211179. PubMed ID: 38529202
[TBL] [Abstract] [Full Text] [Related]
5. Abrogation of KLF5 sensitizes
Zhang Z; Liu Y; Xu Y; Xu Z; Jia J; Jin Y; Wang W; Liu L
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):576-585. PubMed ID: 38433576
[TBL] [Abstract] [Full Text] [Related]
6. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
7. A Prospective Analysis of the Effects of a Powder-Type Hemostatic Agent on the Short-Term Outcomes after liver Resection.
Kang M; Cho JY; Han HS; Yoon YS; Lee HW; Lee B; Park Y; Kim J
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399565
[No Abstract] [Full Text] [Related]
8. A multicenter case-controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3-5 cm hepatocellular carcinoma in patients aged 60 and older.
Wang Z; Zhang H; Meng Q; Zhang DZ; Wu SS; Hong ZX; He GB; Yang H; Xiang BD; Li X; Jiang TA; Li K; Tang Z; Huang F; Lu M; Liu C; Yu XL; Cheng ZG; Liu FY; Han ZY; Dou JP; Yu J; Liang P
Int J Surg; 2024 Mar; 110(3):1356-1366. PubMed ID: 38320101
[TBL] [Abstract] [Full Text] [Related]
9. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Postoperative Recurrence of Bilateral Breast cancer in Which Stable Disease Condition Was Achieved by Olaparib].
Terakawa H; Kawata C; Kurokawa Y; Ooe Y; Mohri R; Hirata M; Moriyama H; Kinoshita J; Kawashima H; Inaki N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1414-1416. PubMed ID: 38303292
[TBL] [Abstract] [Full Text] [Related]
11. Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery.
Raverdy V; Tavaglione F; Chatelain E; Caiazzo R; Saponaro C; Lassailly G; Verkindt H; Baud G; Marciniak C; Chetboun M; Oukhouya-Daoud N; Gnemmi V; Leteurtre E; Duhamel A; Philippe M; Marot G; Romeo S; Pattou F
Metabolism; 2024 Apr; 153():155790. PubMed ID: 38219973
[TBL] [Abstract] [Full Text] [Related]
12. BRCC36 Deubiquitinates HMGCR to Regulate the Interplay Between Ferroptosis and Pyroptosis.
Wang H; Shu L; Lv C; Liu N; Long Y; Peng X; Ling H; Tao T; Tang J; Cheng Y; Liu S; Xiao D; Tao Y
Adv Sci (Weinh); 2024 Mar; 11(11):e2304263. PubMed ID: 38178583
[TBL] [Abstract] [Full Text] [Related]
13. Recombinant human adenovirus p53 combined with transcatheter arterial chemoembolization for liver cancer: A meta-analysis.
Guo Y; Chen Y; Zhang Y; Xu M; Guo W; Zhang J; Ma G; Liu C; Yang J; Wu X
PLoS One; 2023; 18(12):e0295323. PubMed ID: 38127912
[TBL] [Abstract] [Full Text] [Related]
14. Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets.
Shi Y; Dong H; Sun S; Wu X; Fang J; Zhao J; Han J; Li Z; Wu H; Liu L; Wu W; Tian Y; Yuan G; Fan X; Xu C
Clin Mol Hepatol; 2024 Jan; 30(1):80-97. PubMed ID: 38061333
[TBL] [Abstract] [Full Text] [Related]
15. Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016.
Comoz B; Ollivier-Hourmand I; Bouvier AM; Nousbaum JB; Nguyen TTN; Launoy G; Bouvier V; Bryere J
Liver Int; 2024 Feb; 44(2):446-453. PubMed ID: 38010978
[TBL] [Abstract] [Full Text] [Related]
16. High intramuscular adipose tissue content associated with prognosis and postoperative complications of cancers.
Liu R; Qiu Z; Zhang L; Ma W; Zi L; Wang K; Kuang T; Zhao K; Wang W
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2509-2519. PubMed ID: 37990969
[TBL] [Abstract] [Full Text] [Related]
17. Influence of formalin fixation duration on RNA quality and quantity from formalin-fixed paraffin-embedded hepatocellular carcinoma tissues.
Amemiya K; Hirotsu Y; Nagakubo Y; Mochizuki H; Oyama T; Omata M
Pathol Int; 2023 Dec; 73(12):593-600. PubMed ID: 37933792
[TBL] [Abstract] [Full Text] [Related]
18. Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
Lim JZ; Crawford AZ; McGhee CNJ
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
[TBL] [Abstract] [Full Text] [Related]
19. The benefit of pancreatic cancer surveillance in carriers of germline brca1/2 pathogenic variants.
Laish I; Schechter M; Dancour A; Lieberman S; Levi Z; Goldberg Y; Kedar I; Hasnis E; Half E; Levi GR; Katz L; Vainer ED; Genzel D; Aharoni M; Chen-Shtoyerman R; Abu-Freha N; Raitses-Gurevich M; Golan T; Bernstein-Molho R; Ben Yehoyada M; Gluck N; Rosner G
Cancer; 2024 Jan; 130(2):256-266. PubMed ID: 37861363
[TBL] [Abstract] [Full Text] [Related]
20. FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma.
Tang X; Luo B; Huang S; Jiang J; Chen Y; Ren W; Shi X; Zhang W; Shi L; Zhong X; Lü M
Eur J Med Res; 2023 Oct; 28(1):419. PubMed ID: 37821996
[TBL] [Abstract] [Full Text] [Related]
[Next]